Last 1.67 MYR
Change Today +0.03 / 1.83%
Volume 40.6K
YSP On Other Exchanges
Kuala Lumpur
As of 4:50 AM 07/30/14 All times are local (Market data is delayed by at least 15 minutes).

y.s.p.southeast asia holding (YSP) Snapshot

Previous Close
Day High
Day Low
52 Week High
05/14/14 - 1.85
52 Week Low
09/4/13 - 1.13
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for Y.S.P.SOUTHEAST ASIA HOLDING (YSP)

Related News

No related news articles were found.

y.s.p.southeast asia holding (YSP) Related Businessweek News

No Related Businessweek News Found

y.s.p.southeast asia holding (YSP) Details

Y.S.P. Southeast Asia Holding Berhad, an investment holding company, engages in the manufacture, import, export, and trade of pharmaceutical products. The company operates in Trading and Manufacturing segments. Its prescription and non-prescription products include antibacterial and analgesic lozenges, antibiotics, antidiarrheals, antiemetics, antihistamines, antihistamine plus decongestant, antiprotozoal and antiamoebic, antispasmodics, antispasmodics with psycholeptics, drugs for gout therapy, H2-antagonists, antifibrinolytics, nootropics and neurotonics, non-steroidal anti-inflammatory, antipyretics and analgesics, peripheral vasodilators, proton pump inhibitors, skeletal muscle relaxants, antacids, anti-platelets, carminatives, digestive enzymes, expectorants/mucolytic agents, haemorrhoidal preparations, and laxatives; antiasthmatic, anti-diabetic, antifungal, lipid regulating, antihypertensive, antitussive, antiviral, chemotherapeutics, ovulation inductive, antihelmintic, and anticoccidial agents; and steroidal, anorectal, and topical preparations, as well as various traditional medicines. The company’s veterinary pharmaceutical products for aquatic and live stock comprise anthelmintics, antibiotics, antifungals, anticoccidial agent, antipyretics and analgesics, disinfectants, electrolytes, hematopoietic nutrients, herbal extracts, hormones preparations, probiotics, immune enhancers, vitamins and minerals supplements, antimicrobial, larval feeds, and minerals. It offers its products in various formats, such as gels, capsules, tablets, suppositories, creams, syrups, suspensions, and powder dosage forms. In addition, the company provides various products, including disposables, medical devices, test kits, first aids, medical aids, and insect repellents. It operates in Malaysia, Singapore, the Philippines, Vietnam, Cambodia, Myanmar, Brunei, and internationally. The company was founded in 1987 and is headquartered in Kuala Lumpur, Malaysia.

Founded in 1987

y.s.p.southeast asia holding (YSP) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

y.s.p.southeast asia holding (YSP) Key Developments

Y.S.P. Southeast Asia Holding Mulls Acquisitions

Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH) is looking for acquisitions. Managing Director, Datuk Lee Fang Hsin said that the company is looking at the merger and acquisition route for growth and has identified several potential international and local companies. The official, however, declined to elaborate, saying that they are still at the negotiation stage. He said, “We plan to merge [with potential companies] to diversify our product range. However, any acquisitions of companies will be in the same [pharmaceutical] industry. For example, we acquired Sun Ten Pharmaceutical Co Ltd, a manufacturer of herbal extracts from Taiwan, back in 2008 to diversify into traditional herbal products.”

Y.S.P. Southeast Asia Holding Berhad Announces First and Final Single Tier Dividend for the Financial Year Ended December 31, 2013, Payable on August 15, 2014

Y.S.P. Southeast Asia Holding Berhad announced the first and final single tier dividend of 6.5 sen per ordinary share of MYR 1.00 each for the financial year ended December 31, 2013 ad the payment date is on August 15, 2014 and the ex-dividend date is on July 16, 2014.

Y.S.P. Southeast Asia Holding Berhad, Annual General Meeting, Jun 23, 2014

Y.S.P. Southeast Asia Holding Berhad, Annual General Meeting, Jun 23, 2014., at 09:30 Singapore Standard Time. Location: Unity Hall and Stateroom, Lower Ground Floor, Palace of the Golden Horses. Agenda: To consider the audited financial statements of the company and its Group for the financial year ended December 31, 2013 and the reports of the directors and the auditors thereon; to approve the payment of directors' fees for the financial year ended December 31, 2013; to approve a first and final single tier dividend of 6.5 sen per ordinary share of MYR 1.00 each for the financial year ended December 31, 2013; to consider the re-election of the retiring directors; to consider the re-appointment of auditor and to authorize the board of directors to fix their remuneration; to consider the retention of independent directors; to consider the authority to issue shares; to consider the proposed shareholders' mandate for recurrent related party transactions of a revenue or trading nature; and to transact any other business.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
YSP:MK 1.67 MYR +0.03

YSP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for YSP.
View Industry Companies

Industry Analysis


Industry Average

Valuation YSP Industry Range
Price/Earnings 13.0x
Price/Sales 1.2x
Price/Book 1.0x
Price/Cash Flow 13.0x
TEV/Sales 0.7x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Y.S.P.SOUTHEAST ASIA HOLDING, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at